meta
|
Preg
- medecines during pregnancy KB
Search
Thiouracil, propylthiouracil, benzylthiouracil
Overall results
Study description
Excluded studies
Table
Graphic
auto
during pregnancy (anytime or not specified)
1st trimester
2nd trimester
3rd trimester
2nd and/or 3rd trimester
throughout pregnancy
early pregnancy
days before delivery
late pregnancy
preconception-only
periconceptional
preconceptional for kinetic reason
at least 1st trimester
3 months (or more) before pregnancy or during pregnancy
1st and 2nd trimester
3 months or more before pregnancy or1st trimester
Whatever the period exposition
individual studies
Outcome
TE
95% CI
n cases
n exposed
k
Pub. bias
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)
Wing (control unexposed, sick), 1994 Rosenfeld, 2009 Banhidy, 2011 Yoshihara (control unexposed, sick), 2012 Gianetti (control unexposed, sick), 2015 Hawken (control exposed to MMI), 2016 Andersen 2017 (control unexposed, sick), 2017 Seo (control unexposed, NOS), 2018 Andersen 2019 (control unexposed, disease free), 2019 Yoshihara (Controls unexposed, sick), 2021
10
0.99
[
0.81
; 1.21]
249,670
13,223
critical
Major congenital malformations
Wing (control unexposed, sick), 1994 Rosenfeld, 2009 Banhidy, 2011 Yoshihara (control unexposed, sick), 2012 Gianetti (control unexposed, sick), 2015
5
0.68
[
0.45
; 1.05]
179
1,632
not evaluable
Genital anomalies
Andersen 2017 (control unexposed, sick), 2017 Seo (control unexposed, NOS), 2018 Andersen 2019 (control unexposed, disease free), 2019
3
1.22
[
0.96
; 1.54]
25,811
11,037
not evaluable
Limb defects
Andersen 2017 (control unexposed, sick), 2017 Seo (control unexposed, NOS), 2018 Andersen 2019 (control unexposed, disease free), 2019
3
1.20
[
1.05
; 1.37]
74,706
11,037
not evaluable
Respiratory system anomalies
Andersen 2017 (control unexposed, sick), 2017 Seo (control unexposed, NOS), 2018 Andersen 2019 (control unexposed, disease free), 2019
3
1.22
[
0.76
; 1.96]
16,007
11,037
not evaluable
Urinary malformations
Andersen 2017 (control unexposed, sick), 2017 Seo (control unexposed, NOS), 2018 Andersen 2019 (control unexposed, disease free), 2019
3
1.63
[
1.01
; 2.62]
17,696
11,037
not evaluable
Eye defects
Andersen 2017 (control unexposed, sick), 2017 Andersen 2019 (control unexposed, disease free), 2019
2
0.44
[
0.06
; 3.31]
2,484
1,107
not evaluable
Congenital heart defects
Andersen 2017 (control unexposed, sick), 2017 Seo (control unexposed, NOS), 2018 Andersen 2019 (control unexposed, disease free), 2019
3
1.05
[
0.84
; 1.31]
77,568
11,037
not evaluable
Severe congenital heart defect
Clementi, 2010 Yoshihara (control unexposed, sick), 2012
2
1.20
[
0.06
; 22.67]
739
1,446
not evaluable
Abdominal wall defects
Andersen 2017 (control unexposed, sick), 2017 Andersen 2019 (control unexposed, disease free), 2019
2
1.19
[
0.15
; 9.65]
926
1,107
not evaluable
Ano-rectal atresia and stenosis
Yoshihara (control unexposed, sick), 2012 Howley, 2017 Yoshihara (Controls unexposed, sick), 2021
3
1.62
[
0.19
; 14.09]
1,056
1,954
not evaluable
Carbimazole embryopathy
Clementi, 2010 Yoshihara (control unexposed, sick), 2012 Seo (control unexposed, NOS), 2018
3
1.61
[
0.92
; 2.79]
2,243
11,423
not evaluable
Digestive system anomalies
Andersen 2017 (control unexposed, sick), 2017 Seo (control unexposed, NOS), 2018
2
1.47
[
0.59
; 3.67]
12,045
10,148
not evaluable
Nervous system anomalies
Andersen 2017 (control unexposed, sick), 2017 Seo (control unexposed, NOS), 2018
2
1.09
[
0.72
; 1.65]
5,868
10,148
not evaluable
Omphalocele
Clementi, 2010 Yoshihara (control unexposed, sick), 2012 Yoshihara (Controls unexposed, sick), 2021
3
0.79
[
0.19
; 3.23]
159
1,987
not evaluable
Syndromes and chromosomal abnormalities
Andersen 2017 (control unexposed, sick), 2017 Andersen 2019 (control unexposed, disease free), 2019
2
0.84
[
0.33
; 2.12]
5,547
1,107
not evaluable
Atresia of bile ducts
Yoshihara (control unexposed, sick), 2012 Yoshihara (Controls unexposed, sick), 2021
2
0.36
[
0.04
; 3.50]
2
1,940
not evaluable
Cardiac septal defects
0
-
-
-
-
-
Congenital hydronephrosis
Yoshihara (control unexposed, sick), 2012 Yoshihara (Controls unexposed, sick), 2021
2
2.85
[
0.67
; 12.10]
9
1,940
not evaluable
Hypospadias
Yoshihara (control unexposed, sick), 2012 Yoshihara (Controls unexposed, sick), 2021
2
2.38
[
0.35
; 16.30]
4
1,940
not evaluable
Oro-facial clefts
Seo (control unexposed, NOS), 2018 Yoshihara (Controls unexposed, sick), 2021
2
0.98
[
0.56
; 1.70]
3,460
10,471
not evaluable
Ventricular septal defect
Yoshihara (control unexposed, sick), 2012 Yoshihara (Controls unexposed, sick), 2021
2
0.89
[
0.42
; 1.88]
28
1,940
not evaluable
Aortic valve atresia/stenosis
Yoshihara (control unexposed, sick), 2012 Howley, 2017
2
3.29
[
0.12
; 89.46]
494
1,412
not evaluable
Craniosynostosis
Yoshihara (control unexposed, sick), 2012 Howley, 2017
2
1.19
[
0.30
; 4.68]
1,535
1,411
not evaluable
Ear malformations
Andersen 2017 (control unexposed, sick), 2017
1
35.97
[
1.72
; 751.88]
2
218
not evaluable
Ear, face and neck anomalies
Andersen 2017 (control unexposed, sick), 2017
1
2.86
[
0.55
; 14.85]
7
218
not evaluable
Other congenital malformations (Q80-84)
Andersen 2017 (control unexposed, sick), 2017
1
0.37
[
0.02
; 6.43]
9
218
not evaluable
Pulmonary valve stenosis
Howley, 2017 Yoshihara (Controls unexposed, sick), 2021
2
0.77
[
0.15
; 4.01]
1,517
552
not evaluable
Situs inversus
Clementi, 2010 Yoshihara (control unexposed, sick), 2012
2
15.05
[
1.80
; 126.08]
27
1,446
not evaluable
Aplasia cutis congenita
Yoshihara (control unexposed, sick), 2012
1
1.36
[
0.03
; 68.71]
-
1,399
not evaluable
Atresia or stenosis of other parts of small intestine
Yoshihara (control unexposed, sick), 2012
1
1.36
[
0.03
; 68.71]
-
1,399
not evaluable
Atrial septal defect
Yoshihara (control unexposed, sick), 2012
1
2.73
[
0.25
; 30.11]
3
1,399
not evaluable
Brachydactyly
Yoshihara (control unexposed, sick), 2012
1
4.09
[
0.17
; 100.49]
1
1,399
not evaluable
Chromosomal abnormalities
Gianetti (control unexposed, sick), 2015
1
4.02
[
0.55
; 29.24]
4
52
not evaluable
Cleft lip with or without cleft palate
Yoshihara (control unexposed, sick), 2012
1
0.68
[
0.06
; 7.52]
3
1,399
not evaluable
Club foot / Talipes equinovarus
Yoshihara (control unexposed, sick), 2012
1
0.45
[
0.02
; 11.15]
1
1,399
not evaluable
Congenital cataract
Yoshihara (control unexposed, sick), 2012
1
0.45
[
0.02
; 11.15]
1
1,399
not evaluable
Diaphragmatic hernia
Yoshihara (control unexposed, sick), 2012
1
0.45
[
0.02
; 11.15]
1
1,399
not evaluable
Down syndrom / Trisomy 21
Yoshihara (control unexposed, sick), 2012
1
1.36
[
0.19
; 9.69]
4
1,399
not evaluable
Eye, ear, face and neck malformations
Seo (control unexposed, NOS), 2018
1
1.21
[
0.89
; 1.64]
9,484
9,930
not evaluable
Intestinal malrotation
Yoshihara (control unexposed, sick), 2012
1
0.45
[
0.05
; 4.37]
4
1,399
not evaluable
Multicystic renal dysplasia
Yoshihara (control unexposed, sick), 2012
1
0.45
[
0.02
; 11.15]
1
1,399
not evaluable
Oesophageal atresia with or without tracheo-oesophageal fistula
Yoshihara (control unexposed, sick), 2012
1
1.36
[
0.03
; 68.71]
-
1,399
not evaluable
Other congenital malformations (Q80 to Q99)
Seo (control unexposed, NOS), 2018
1
1.14
[
0.84
; 1.55]
10,064
9,930
not evaluable
Patent ductus arterious
Yoshihara (control unexposed, sick), 2012
1
4.09
[
0.17
; 100.49]
1
1,399
not evaluable
Polydactyly
Yoshihara (Controls unexposed, sick), 2021
1
2.64
[
0.11
; 64.93]
1
541
not evaluable
Pulmonary artery stenosis
Yoshihara (control unexposed, sick), 2012
1
0.45
[
0.02
; 11.15]
1
1,399
not evaluable
Spina bifida
Yoshihara (control unexposed, sick), 2012
1
4.09
[
0.17
; 100.49]
1
1,399
not evaluable
Sturge-Weber syndrome
Yoshihara (control unexposed, sick), 2012
1
1.36
[
0.03
; 68.71]
-
1,399
not evaluable
Syndactyly
Yoshihara (control unexposed, sick), 2012
1
4.09
[
0.43
; 39.40]
4
1,399
not evaluable
Tetralogy of Fallot
Yoshihara (control unexposed, sick), 2012
1
4.09
[
0.17
; 100.49]
1
1,399
not evaluable
Transposition of the great vessels
Yoshihara (control unexposed, sick), 2012
1
0.45
[
0.02
; 11.15]
1
1,399
not evaluable
Choanal atresia
Clementi, 2010
1
3.31
[
0.20
; 54.40]
58
47
not evaluable
Coarctation of aorta
Howley, 2017
1
7.97
[
1.64
; 38.62]
1,137
14
not evaluable
Gastroschisis
Howley, 2017
1
1.62
[
0.36
; 7.42]
1,393
12
not evaluable
Growth parameters and prematurity
Preterm (< 37 weeks)
Rosenfeld, 2009 Chen (control unexposed, sick), 2011 Gianetti (control unexposed, sick), 2015 Zhang, 2016
4
1.06
[
0.65
; 1.72]
291
825
not evaluable
Low birth weight (< 2500g)
Chen (control unexposed, sick), 2011
1
1.40
[
1.00
; 1.96]
182
630
not evaluable
Small for gestational age (weight)
Chen (control unexposed, sick), 2011
1
1.05
[
0.83
; 1.32]
479
630
not evaluable
Maternal consequences
Maternal liver disorder / failure during pregnancy
Lo (control exposed to MMI), 2015
1
0.42
[
0.02
; 10.52]
1
556
not evaluable
Caesarean
Gianetti (control unexposed, sick), 2015 Zhang, 2016
2
1.09
[
0.31
; 3.78]
97
95
not evaluable
Preeclampsia
Davis, 1989 Gianetti (control unexposed, sick), 2015
2
0.45
[
0.09
; 2.24]
8
104
not evaluable
Gestational diabetes
Gianetti (control unexposed, sick), 2015
1
1.30
[
0.05
; 32.49]
1
52
not evaluable
Neonatal disorders
Goiter
Davis, 1989 Momotani (control exposed to MMI), 1997 Gianetti (control unexposed, sick), 2015 Hawken (control exposed to MMI), 2016
4
1.40
[
0.36
; 5.48]
8
160
not evaluable
Hypothyroidism (fetal/neonatal)
Davis, 1989 Wing (control unexposed, sick), 1994 Hawken (control exposed to MMI), 2016
3
0.97
[
0.15
; 6.38]
3
173
not evaluable
Hearing loss / Auditory deficit
Yoshihara (control unexposed, sick), 2012 Yoshihara (Controls unexposed, sick), 2021
2
0.43
[
0.06
; 3.05]
4
1,940
not evaluable
Hyperthyroidism / Thyrotoxicosis (fetal/neonatal)
Davis, 1989 Hawken (control exposed to MMI), 2016
2
0.83
[
0.08
; 8.47]
2
74
not evaluable
Neonatal hyperthyrotropinemia
Momotani (control exposed to MMI), 1997 Gianetti (control unexposed, sick), 2015
2
3.82
[
0.36
; 40.91]
15
86
not evaluable
Intrauterine deaths
Elective/induced termination of pregnancy
Rosenfeld, 2009 Yoshihara (control unexposed, sick), 2012 Gianetti (control unexposed, sick), 2015
3
1.32
[
0.72
; 2.42]
67
1,745
not evaluable
Early intrauterine death (< 22 weeks)
Davis, 1989 Rosenfeld, 2009 Yoshihara (control unexposed, sick), 2012
3
1.24
[
0.62
; 2.47]
394
1,745
not evaluable
Intrauterine deaths (as a whole or unspecified)
Gianetti (control unexposed, sick), 2015 Zhang, 2016
2
1.24
[
0.51
; 3.02]
25
95
not evaluable
Perinatal death
Yoshihara (control unexposed, sick), 2012 Gianetti (control unexposed, sick), 2015
2
2.00
[
0.17
; 23.33]
19
1,630
not evaluable
Late intrauterine deaths (> 22 weeks)
Davis, 1989 Rosenfeld, 2009
2
0.20
[
0.01
; 6.47]
9
167
not evaluable
Ectopic pregnancy
0
-
-
-
-
-
0.0
100.0
1.0